University Briefs

Betting On Biotech Some states use lotteries to finance vital needs that could not be met by their annual budgets. One state, for example, might earmark lottery profits for education, another for programs to aid its elderly. Legislators in Iowa, which is largely dependent on agricultural growth, took a look at the needs of their state—and decided that one pressing need was more biotech. Every year since 1986 the state lottery agency has turned over $4.25 million to Iowa Slate University&

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Some states use lotteries to finance vital needs that could not be met by their annual budgets. One state, for example, might earmark lottery profits for education, another for programs to aid its elderly. Legislators in Iowa, which is largely dependent on agricultural growth, took a look at the needs of their state—and decided that one pressing need was more biotech. Every year since 1986 the state lottery agency has turned over $4.25 million to Iowa Slate University’s biotechnology program, which in turn must match that figure with outside research grants (a task it has performed without difficulty). The money has been used to hire 21 researchers and fund more than 35 research projects, including the first field test at a U.S. university of a genetically engineered organism. Walter Fehr, director of the ISU program, credits the lottery with transforming the state’s biotechnology industry: “It took us from being out ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies